Correction of Warfarin Coagulopathy for Non-bleeding Patients in the Outpatient Setting at an Ambulatory Care Organization: Application of Vitamin K Guidance.
Aaminah KhanDavid DeiCicchiPeter CollinsAshwini RanadeKathy ZaikenPublished in: Cardiovascular & hematological agents in medicinal chemistry (2024)
Our internal guidance is a novel, standardized approach that serves as a decision support tool for the management of warfarin-associated coagulopathy and vitamin K intervention using patient-specific characteristics and index INR values. This guidance may assist other anticoagulation management services with practical applications and require validation in a prospective clinical trial.
Keyphrases
- atrial fibrillation
- venous thromboembolism
- clinical trial
- healthcare
- end stage renal disease
- direct oral anticoagulants
- randomized controlled trial
- chronic kidney disease
- ejection fraction
- newly diagnosed
- blood pressure
- primary care
- palliative care
- oral anticoagulants
- mental health
- prognostic factors
- study protocol
- double blind
- pain management
- phase iii